-
If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Lawsuit Overview
<p align= justify >The original Complaint alleges that during the Class Period defendants, GlaxoSmithKline PLC and certain of its officers, violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by publicly issuing a series of false and misleading statements regarding Avandia, GSK’s popular diabetes drug.</p> <p align= justify > </p> <p al...
You must register (for free) or login to view the entire case.
